AIM1 and LINE-1 Epigenetic Aberrations in Tumor and Serum Relate to Melanoma Progression and Disease Outcome
Open Access
- 30 June 2012
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 132 (6), 1689-1697
- https://doi.org/10.1038/jid.2012.36
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancerGenome Research, 2010
- Functional RET G691S polymorphism in cutaneous malignant melanomaOncogene, 2009
- A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon CancerJNCI Journal of the National Cancer Institute, 2008
- Exploring the Limits of Sequence and Structure in a Variant βγ-Crystallin Domain of the Protein Absent in Melanoma-1 (AIM1)Journal of Molecular Biology, 2008
- LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancerInternational Journal of Cancer, 2008
- Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvementsNucleic Acids Research, 2007
- The Epigenomics of CancerCell, 2007
- Hypermethylation of CpG island loci and hypomethylation of LINE‐1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological featuresThe Journal of Pathology, 2006
- Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesisOncogene, 2004
- Initial sequencing and analysis of the human genomeNature, 2001